Literature DB >> 31042325

Modulation of miR-34a in curcumin-induced antiproliferation of prostate cancer cells.

Mingming Zhu1,2, Zongmei Zheng1, Jiaming Huang1, Xiao Ma2, Cong Huang2, Rui Wu2, Xiaoting Li3,2, Zhaofeng Liang2, Feifei Deng2, Jieshu Wu3,2, Shanshan Geng3,2, Chunfeng Xie3,2, Caiyun Zhong3,2.   

Abstract

Curcumin is a phytochemical which exhibits significant inhibitory effect in multiple cancers including prostate cancer. MicroRNA-34a (miR-34a) was found to be a master tumor suppressor miRNA and regulated the growth of cancer cells. To date, however, the role of miR-34a in the anticancer action of curcumin against prostate cancer has been rarely reported. In the present study, we showed that curcumin altered the expression of cell cycle-related genes (cyclin D1, PCNA, and p21) and inhibited the proliferation of prostate cancer cells. Furthermore, we found that curcumin significantly upregulated the expression of miR-34a, along with the downregulated expression of β-catenin and c-myc in three prostate cancer cell lines. Inhibition of miR-34a activated β-catenin/c-myc axis, altered cell cycle-related genes expression and significantly suppressed the antiproliferation effect of curcumin in prostate cancer cells. Findings from this study revealed that miR-34a plays an important role in the antiproliferation effect of curcumin in prostate cancer.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  cell proliferation; curcumin; miR-34a; prostate cancer; β-catenin/c-myc

Year:  2019        PMID: 31042325     DOI: 10.1002/jcb.28828

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  19 in total

1.  Preparation of Ergosterol-Loaded Nanostructured Lipid Carriers for Enhancing Oral Bioavailability and Antidiabetic Nephropathy Effects.

Authors:  Zhonghua Dong; Sajid Iqbal; Zhongxi Zhao
Journal:  AAPS PharmSciTech       Date:  2020-01-13       Impact factor: 3.246

2.  A promising effect of zerumbone with improved anti-tumor-promoting inflammation activity of miR-34a in colorectal cancer cell lines.

Authors:  Razieh Dehghan; Rezvan Najafi; Farid Azizi Jalilian; Massoud Saidijam; Zahra Radaei; Alireza Zamani; Razieh Ezati; Farzaneh Asna-Ashari; Razieh Amini
Journal:  Mol Biol Rep       Date:  2021-01-04       Impact factor: 2.316

3.  Cellular uptake and apoptotic properties of gemini curcumin in gastric cancer cells.

Authors:  Ali Emami; Esmaeil Babaei; Alaadin Nagishbandi; Hewa Jalal Azeez; Mohammad Ali Hosseinpour Feizi; Ashraf Golizadeh
Journal:  Mol Biol Rep       Date:  2021-10-08       Impact factor: 2.316

Review 4.  MicroRNA mediated therapeutic effects of natural agents in prostate cancer.

Authors:  Km Anjaly; A B Tiku
Journal:  Mol Biol Rep       Date:  2021-07-24       Impact factor: 2.316

5.  Curcumin-Alleviated Osteoarthritic Progression in Rats Fed a High-Fat Diet by Inhibiting Apoptosis and Activating Autophagy via Modulation of MicroRNA-34a.

Authors:  Jiayu Yao; Xiaotong Liu; Yingxu Sun; Xin Dong; Li Liu; Hailun Gu
Journal:  J Inflamm Res       Date:  2021-06-01

6.  Curcumin suppresses osteogenesis by inducing miR-126a-3p and subsequently suppressing the WNT/LRP6 pathway.

Authors:  Hongling Li; Lifeng Yue; Haoying Xu; Na Li; Jing Li; Zhiguo Zhang; Robert Chunhua Zhao
Journal:  Aging (Albany NY)       Date:  2019-09-03       Impact factor: 5.682

7.  Sanggenol L Induces Apoptosis and Cell Cycle Arrest via Activation of p53 and Suppression of PI3K/Akt/mTOR Signaling in Human Prostate Cancer Cells.

Authors:  Yeong-Seon Won; Kwon-Il Seo
Journal:  Nutrients       Date:  2020-02-14       Impact factor: 5.717

Review 8.  Curcumin against Prostate Cancer: Current Evidence.

Authors:  Deborah Termini; Danja J Den Hartogh; Alina Jaglanian; Evangelia Tsiani
Journal:  Biomolecules       Date:  2020-11-10

Review 9.  Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets.

Authors:  Fabrizio Fontana; Michela Raimondi; Monica Marzagalli; Alessandro Di Domizio; Patrizia Limonta
Journal:  Cells       Date:  2020-02-18       Impact factor: 6.600

Review 10.  Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives.

Authors:  Ebrahim Rahmani Moghadam; Hui Li Ang; Sholeh Etehad Asnaf; Amirhossein Zabolian; Hossein Saleki; Mohammad Yavari; Hossein Esmaeili; Ali Zarrabi; Milad Ashrafizadeh; Alan Prem Kumar
Journal:  Biomolecules       Date:  2020-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.